Logo
    Search

    Following the cannabis money trail (encore episode)

    enSeptember 04, 2018

    Podcast Summary

    • From retirement to marijuana business: A new chapter in the industry's growthFormer IT project manager Norman Condie and his wife leave retirement to open a marijuana dispensary in Massachusetts, inspired by potential benefits for their son and others. Industry's growth attracts billions in investments, but federal illegality poses challenges.

      The legalized cannabis industry in North America is experiencing significant growth, with billions of dollars at stake. This has attracted numerous entrepreneurs and investors, including Constellation Brands' recent $4 billion investment in Canopy Growth, the largest in the sector to date. One such entrepreneur is Norman Condie, a former IT project manager, who, along with his wife, is leaving their Virginia home to open a marijuana dispensary in Massachusetts. Despite skepticism from some, they were inspired by the potential benefits of medical marijuana for their son and others with health conditions. The industry's growth, however, comes with challenges, as marijuana remains illegal under federal law. As of April 2023, Massachusetts had 26 registered medical dispensaries serving about 50,000 patients. This shift from retirement plans to opening a marijuana business is a testament to the industry's potential and the personal stories behind the boom.

    • Starting a medical marijuana business involves high costsCouples planning a medical marijuana business face costs ranging from $160k to $3M, including fees, rent, and equipment

      Starting a medical marijuana business comes with significant costs and challenges. Norman and his wife, who lost their son Ryan to leukemia and believe medical marijuana could have improved his quality of life, are planning to invest around $400,000 in their new venture. This includes fees, renting a space, and purchasing equipment for both the dispensary and grow shop. The cost to set up a medical marijuana business ranges from $160,000 to $3 million. Despite the high costs, Norman and his wife are determined to provide relief to patients like their son. However, they are not alone in their entrepreneurial endeavors in the local medical marijuana industry.

    • Businesses providing products and services to the cannabis industry without directly handling the plant are poised for growth in MassachusettsKUSH Bottles, a company offering labels, hardware for vaporizers, and hydrocarbon gases for extracting oils, is well-positioned to benefit from the legalization of recreational marijuana in Massachusetts and potentially abroad due to its unique business model and growing sales.

      The legalization of recreational marijuana in Massachusetts presents a significant growth opportunity for businesses that provide products and services to the cannabis industry without directly handling the plant. Companies like KUSH Bottles, which offers labels, hardware for vaporizers, and hydrocarbon gases for extracting oils, are well-positioned to benefit from the industry's expansion in the US and potentially abroad. With a market cap of $400 million and sales of $18.8 million in its 2017 fiscal year, KUSH Bottles is poised for further growth as more states in the US legalize marijuana. The company's unique business model allows it to appeal to investors who may be restricted from investing in companies that directly touch the plant due to their charter agreements. Massachusetts, with its unique market characteristics, is an exciting opportunity for KUSH Bottles as it expands its footprint in the US.

    • Massachusetts' proximity to other states drives cannabis economic growthMassachusetts' proximity to underdeveloped medical marijuana states and upcoming Canadian recreational legalization could lead to increased demand, business opportunities, and tax revenue.

      The legalization of cannabis in Massachusetts is expected to bring significant economic benefits to the state due to its proximity to other East Coast states with less accessible or underdeveloped medical marijuana programs. This could lead to increased demand and business opportunities in Massachusetts, keeping the tax revenue within the state and potentially influencing other states to legalize for similar reasons. Additionally, the upcoming legalization of recreational marijuana in Canada is anticipated to bring the previously untaxed black market into the light, leading to further growth opportunities and analysis from rating agencies regarding the potential impact on tax bases and services.

    • The Legal Marijuana Market: A Growing Industry with Significant Economic ImpactThe legal marijuana market is projected to reach $7-$20 billion, encompassing growers, sellers, labs, and online marketplaces. Canadian companies lead the way, with significant economic impact expected from new products and industries.

      The legal marijuana market is rapidly expanding, with increasing public acceptance and political will for legalization leading the way. Companies are eager to establish a presence in this growing industry, and estimates for its size range from $7 billion to over $20 billion in the next few years. This market encompasses various sectors, including growers, sellers, labs, and online marketplaces. The potential economic impact is significant, with new products and industries expected to emerge as demand materializes. Despite variations in prices and regulations, Statistics Canada estimates an average national price of around $6.83 per gram. Canadian companies, many of which are listed in Toronto, are at the forefront of this industry, with major Canadian banks involved due to the legal complexities in the US. Notable deals include Aurora Cannabis' takeover of MedRelief for over $2 billion. Overall, the legal marijuana market is seen as the next major growth industry, rivaling tobacco and alcohol.

    • Rush of interest from large corporations in cannabis industryLarge corporations see potential for cannabis oligopoly but investing comes with significant risks due to uncertain market potential, competition, regulation, and lack of commodity exchange.

      The cannabis industry is experiencing a rush of interest from large corporations due to its potential for becoming an oligopoly in the future. However, investing in this space comes with significant risks. The market potential is vast, but uncertain, with many factors such as competition, regulation, and market size still unknown. While some states have seen success in tax revenue from legalization, there are concerns about how this will impact markets in other areas and how competition will affect business models. The industry is currently privately operated, and there is no commodity exchange for trading cannabis. These unknowns have attracted early adopting entrepreneurs and investors, but also highlight the risks involved.

    • UnitedHealthcare: Coverage for life's transitions, 1800flowers.com: Delivering smilesUnitedHealthcare offers flexible short term insurance plans for individuals during life transitions, while 1800flowers.com brings joy through carefully crafted floral arrangements

      UnitedHealthcare's short term insurance plans are ideal for individuals in transition periods of their lives, such as job changes, aging off their parents' plans, or starting a full-time business. These plans, underwritten by Golden Rule Insurance Company, offer flexible and budget-friendly coverage with access to a vast network of healthcare providers across the country. Meanwhile, 1800flowers.com is not just a popular destination for gifting flowers for birthdays, anniversaries, or "just because." Instead, it's a company that prides itself on delivering smiles by putting heart and care into every step of the flower-making process. In essence, UnitedHealthcare provides essential health coverage for those in need, while 1800flowers.com offers a way to brighten someone's day with thoughtfully crafted floral arrangements. Both companies emphasize the importance of delivering value and positivity in their respective industries. For more information on UnitedHealthcare short term plans, visit uhone.com, and for 1800flowers.com offerings, check out 1800flowers.com/acast.

    Recent Episodes from Behind the Money

    Will Exxon make or break Guyana?

    Will Exxon make or break Guyana?

    Exxon Mobil struck black gold in 2015 when it discovered a massive oil reserve off the coast of Guyana in South America. It’s poised to make Guyana the fourth-largest offshore oil developer in the world, and it's already jump-started a transformation within the developing economy. But will this oil bonanza benefit Guyana’s people? The FT’s US energy editor Jamie Smyth travels to Guyana’s capital to understand Exxon’s impact first-hand. 


    Clip from NBC News

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    For further reading:

    The giant Exxon project that could create the world’s last petrostate

    Oil-rich Guyana tries to tap another source of cash: carbon credits

    Exxon’s exit marks reversal of fortune for Equatorial Guinea

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    On X, follow Jamie Smyth (@JamieSmythF) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enJune 26, 2024

    Bankers vs the Fed: ‘Endgame’

    Bankers vs the Fed: ‘Endgame’

    Banks in the US are locked in a bitter fight with regulators. It’s all about a proposed set of rules with an unusual name, Basel III Endgame. Regulators say the rules will help avoid future banking crises. Banks say they’re overkill and could hurt everyday Americans. The FT’s US banking editor Joshua Franklin explains how the industry is pushing back.


    Clips from Bloomberg, CNBC

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    For further reading:

    The US pushback against ‘Basel Endgame’

    The bank argument on the Basel III endgame is bunk

    EU to delay Basel bank trading reforms as US revisits plans

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    On X, follow Joshua Franklin (@FTJFranklin) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more. 


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enJune 19, 2024

    The wrinkle in Shein’s IPO plans

    The wrinkle in Shein’s IPO plans

    In November, online fast-fashion giant Shein filed paperwork to go public in the US. Since then the process has not moved forward at all — and it looks like Shein’s ties to Beijing could be to blame. The FT’s China tech correspondent Eleanor Olcott explains how Shein has tried to distance itself from China to appease US regulators, and where it might go public instead. 


    Clips from Reuters, Bloomberg, Yahoo Finance

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    For further reading:

    Shein switches focus to London after New York IPO stalls

    Shein’s London IPO flirtation

    Shein profits double to over $2bn ahead of planned listing

    Fund managers give cool reception to prospect of Shein London IPO

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    On X, follow Eleanor Olcott (@EleanorOlcott) and Saffeya Ahmed (@saffeya_ahmed).


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enJune 12, 2024

    Can anyone afford an NBA team?

    Can anyone afford an NBA team?

    The 2024 NBA Playoffs are in full swing, but eyes are still on a team that was knocked out last week. The Minnesota Timberwolves are caught up in an ownership dispute that’s gone south pretty fast, after two prospective buyers attempted to finance their purchase of the team in an unconventional way. The FT’s US sports business correspondent Sara Germano breaks down how the deal came together, fell apart, and the can of worms it’s since opened about owning US sports teams. 


    Clips from Bleacher Report, FOX 9 Minneapolis-St. Paul, KARE 11, House of Highlights, The Dane Moore NBA Podcast

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    For further reading:

    The off-the-court fight for one of the NBA’s hottest teams

    Private equity gears up for potential National Football League investments

    Michael Jordan agrees to sell majority stake in NBA’s Charlotte Hornets

    Mark Cuban’s Mavericks bet

    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    On X, follow Sara Germano (@germanotes) and Saffeya Ahmed (@saffeya_ahmed).


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enJune 05, 2024

    Best Of: Inside a hedge fund disaster

    Best Of: Inside a hedge fund disaster

    This week, we’re revisiting an episode from last November, about a Wall Street saga that lost shareholders more than $10bn. In 2007, when Dan Och took his hedge fund public, he was making a bet that his company would stand the test of time. More than 15 years, a bribery scandal, and a feud with his protégé later, the FT’s Ortenca Aliaj and Sujeet Indap explain how things did not work out as planned. 

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    For further reading:

    Sculptor Capital: grey areas cause grey hairs in messy bidding war

    Fight over Sculptor hedge fund sale entwined in Daniel Och’s tax affairs

    Sale of Sculptor Capital on cusp of approval after hedge fund brawl

    - - - - - - - - - - - - - - - - - - - - - - - - - - 

    On X, follow Ortenca Aliaj (@OrtencaAl), Sujeet Indap (@sindap) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more. 


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enMay 29, 2024

    Why auditors are missing red flags

    Why auditors are missing red flags

    Episode description: 


    Audit firms are supposed to put a company’s books under the microscope. But these days, regulators are finding an increasing number of flaws in the audits that they inspect. The FT’s US accounting editor Stephen Foley explains what’s going wrong, and how regulators around the world plan to fix these shortcomings. 


    Clips from CNN, NBC News 


    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    For further reading:

    Why don’t auditors find fraud?

    Auditors failed to raise alarm before 75% of UK corporate collapses

    Big Four firms rethink governance after year of mis-steps and scandals 


    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    On X, follow Stephen Foley (@stephenfoley) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enMay 22, 2024

    Introducing Untold: Power for Sale

    Introducing Untold: Power for Sale

    Introducing Power for Sale, a new season of Untold from the Financial Times. In Untold: Power for Sale, host Valentina Pop and a team of FT correspondents from all over Europe investigate what happened in the Qatargate scandal, where EU lawmakers were accused of accepting payments from Qatar to whitewash its image.


    Subscribe and listen on: Apple Podcasts, Spotify or wherever you get your podcasts.



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enMay 20, 2024

    Dispatch from Omaha: Berkshire after Warren Buffett

    Dispatch from Omaha: Berkshire after Warren Buffett

    Late last year, Warren Buffett’s close business confidant Charlie Munger died at 99. Munger’s death and Buffett’s upcoming 94th birthday have renewed questions about the future of Berkshire Hathaway. What will the empire he’s built look like after he’s no longer at the helm? 


    Behind the Money and the FT’s senior corporate finance correspondent Eric Platt travel to Omaha, Nebraska for Berkshire Hathaway’s annual shareholder meeting, to get a better sense of how the next generation will lead America’s “last great” conglomerate. 

     

    Clips from CNBC


    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    For further reading:


    Berkshire after Buffett: is Greg Abel up to the top job?

    Berkshire after Buffett: prized energy business faces upheaval

    Berkshire after Buffett: the risk ‘genius’ pulling the insurance strings

    Berkshire after Buffett: can any stockpicker follow the Oracle?


    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    On X, follow Eric Platt (@ericgplatt) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enMay 15, 2024

    Coming soon: China, the new tech superpower

    Coming soon: China, the new tech superpower

    In a new season of Tech Tonic, longtime FT China reporter Jame Kynge travels around the world to see how China is pushing towards tech supremacy. Will China be able to get an edge in crucial technological areas? What does China’s attempt to leapfrog the west look like on the ground? A 6-part series looking at China’s tech industry.


    Presented by James Kynge. Edwin Lane is the senior producer. The producer is Josh Gabert-Doyon. Executive producer is Manuela Saragosa. Sound design by Breen Turner and Samantha Giovinco, with original music from Metaphor Music. The FT’s head of audio is Cheryl Brumley.



    Hosted on Acast. See acast.com/privacy for more information.


    Behind the Money
    enMay 10, 2024

    Was the Archegos implosion illegal?

    Was the Archegos implosion illegal?

    Three years ago, chaos struck Wall Street. Companies saw their share prices tumble, seemingly out of nowhere. Major banks lost billions of dollars in the fallout. Eventually, that chaos was linked to a family office, Archegos Capital Management, and its founder Bill Hwang. 


    This week, Hwang heads to trial in New York, where he faces charges including racketeering, and securities and wire fraud. The FT’s US legal correspondent Joe Miller examines the “novel” case prosecutors plan to pursue.

     

    Clips from CNBC, Fox Business


    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    For further reading:

    ‘To what end?’: the murky question of Bill Hwang’s motive in Archegos trial

    Archegos founder’s charity was financial ‘escape pod’, suit alleges

    Hedge funds and brokers take aim at post-Archegos trading reforms


    - - - - - - - - - - - - - - - - - - - - - - - - - - 


    On X, follow Joe Miller (@JoeMillerJr) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.


    Related Episodes

    Growing Off Grid: How to Build a Sustainable Cannabis Cultivation Facility

    Growing Off Grid: How to Build a Sustainable Cannabis Cultivation Facility

    In this episode of Seed to CEO, Edward Dow, CEO of Massachusetts-based Solar Therapeutics, talks with MJBiz CEO Chris Walsh about how he built his “island microgrid” to support his cannabis company’s sustainability strategy - from unexpected expenses and pitfalls to the creation of a scalable, repeatable model for new markets.

    Ed shares:

    • The real costs of building his vision for a fully off-grid facility and how that compared to staying on the traditional grid.
    • His unconventional path to raising capital to start the company.
    • Critical lessons learned along the way that will make repeating his model even more efficient.

    Who is Edward Dow?

    Ed Dow left a job with the Woods Hole Oceanographic Institution tagging whales and driving underwater vehicles to break into Massachusetts’ highly regulated cannabis industry. His first attempt at securing a medical license ultimately failed, but it helped Ed impress investors who enthusiastically bought into his next - and current - endeavor. Today, Ed’s operations model could be the future of cannabis cultivation.

    Out of Thin Ayr: How to Make Money in Cannabis in Three Short Years

    Out of Thin Ayr: How to Make Money in Cannabis in Three Short Years

    In this episode of Seed to CEO, Ayr Wellness’ Jonathan Sandelman floats tips and insights for building a national MSO. Jonathan talks with MJBiz CEO Chris Walsh about his ambitious goal - being the largest-scale producer of high-quality flower - and how he plans to achieve it.

    Jonathan shares his insights on:

    • Where he sees the best and biggest opportunities for the industry.
    • How Ayr has managed to become cash-flow positive in less than three years while many other firms are still struggling.
    • His strategy for making successful acquisitions.

    Who is Jonathan Sandelman?

    Jonathan is the chair and CEO of Ayr Wellness, a vertically integrated MSO operating in eight states. A mathematician at his core, Sandelman started his 30-year financial career managing derivatives and arbitrage at Salomon Brothers and then Bank of America Securities, where he served as president. He later founded and led his own multibillion-dollar asset management firm, Sandelman Partners. In addition to his current role at Ayr, Jonathan manages his privately held family office, Mercer Park.

    A Fight For Fairness in Legal Weed with Caroline Pineau

    A Fight For Fairness in Legal Weed with Caroline Pineau
    Entrepreneurs face high hurdles before they can enter the legal cannabis industry. Especially in Massachusetts, where potential business owners have to get Host Community Agreements with their cities or towns, which include the controversial 'Community Impact Fee.' Lately, more and more company owners say their towns are charging small canna-businesses the maximum amount allowed by law, not because they are impacting the community, but simply because they can.

    This episode, Brit talks to Caroline Pineau, owner of Stem adult-use cannabis dispensary. Caroline is the first cannabis business owner in the state to sue her host city over the legitimacy of the Community Impact Fee. Her lawsuit alleges that the City of Haverhill is requiring the maximum impact fee from her business without providing any itemized documentation of how it incurred the costs, or how those costs are reasonably related to the pot shop. It's considered a landmark case, which has the potential to change the way the entire cannabis industry operates in the state of Massachusetts.

    Find all the issues of Different Leaf the Magazine at DifferentLeaf.com, or on the shelves at Barnes and Noble Bookstores. Follow us on social media @DifferentLeaf and @Different_Leaf, and follow host Brit Smith @BritTheBritish.

    Produced by Brit Smith and Andrea Muraskin, music by Homebody.

    Reviewing 2021 with Dan Adams of The Boston Globe

    Reviewing 2021 with Dan Adams of The Boston Globe
    There were a lot of major changes this year when it comes to legal weed in Massachusetts. We saw a huge increase in licensed cannabis businesses, including the first recreational delivery licenses, a groundbreaking lawsuit that could shape the way the state’s marijuana industry functions, and the reemergence of the conversation around cannabis in sports.

    Joining Brit to break down all this year's top pot stories is Boston Globe cannabis reporter Dan Adams. From his weekly newsletter “This Week In Weed" to his most recent overview of what has happened since Mass. legalized pot five years ago, Dan has continued to give detailed coverage of all the biggest moves in Massachusetts cannabis.

    Different Leaf will be back in the New Year with more great podcast episodes and some brand new issues of Different Leaf the Magazine, which you can buy at DifferentLeaf.com, or at Barnes and Noble Bookstores. Follow us on social media @Different Leaf and @Different_Leaf, and follow host Brit Smith @BritTheBritish.

    Produced by Andrea Muraskin and Brit Smith, music by Homebody.

    Consultant to MSO to Exit: An Industry Pioneer’s Cannabis Journey

    Consultant to MSO to Exit: An Industry Pioneer’s Cannabis Journey

    Before it became one of the biggest multistate operators in the United States, 4Front Ventures was a consulting firm, 4Front Advisors. But change in the cannabis industry coupled with frustration over collecting fees led Kris Krane and his colleagues to change direction. In this episode of Seed to CEO, Kris talks with MJBiz CEO Chris Walsh about the ups and downs of the decision – and what’s next as he steps away from 4Front’s day-to-day operations.

    Kris shares:

    • How his team plugged the knowledge gaps in the shift from consulting firm to a vertically integrated operator.
    • Tips on how to successfully scale a plant-touching business across diverse markets.
    • How to know when it’s time to exit your business.

    Who is Kris Krane?

    Industry veteran Kris Krane recently stepped down from his executive role at 4Front Ventures, which he co-founded in February 2011. Today the company is one of the most influential MSOs in the nation with more than 500 employees. Kris’ cannabis roots are in advocacy, including as executive director of Students for Sensible Drug Policy. He’s still in cannabis today as an independent consultant and CEO at Kranewreck Enterprises. He is also a principal owner and president of Anderson Leonard Pharmaceuticals, a licensed cultivator, producer and exporter in North Macedonia.